Airway epithelium is the primary target of many respiratory viruses. However, virus induction and antagonism of host responses by human airway epithelium remains poorly understood. To address this, we developed a model of respiratory syncytial virus (RSV) infection based on well-differentiated pediatric primary bronchial epithelial cell cultures (WD-PBECs) that mimics hallmarks of RSV disease in infants. RSV is the most important respiratory viral pathogen in young infants worldwide. We found that RSV induces a potent antiviral state in WD-PBECs that was mediated in part by secreted factors, including interferon lambda 1 (
IMPORTANCEMost respiratory viruses target airway epithelium for infection and replication, which is central to causing disease. However, for most human viruses we have a poor understanding of their interactions with human airway epithelium. Respiratory syncytial virus (RSV) is the most important viral pathogen of young infants. To help understand RSV interactions with pediatric airway epithelium, we previously developed three-dimensional primary cell cultures from infant bronchial epithelium that reproduce several hallmarks of RSV infection in infants, indicating that they represent authentic surrogates of RSV infection in infants. We found that RSV induced a potent antiviral state in these cultures and that a type III interferon, interleukin IL-29 (IL-29), was involved. Indeed, our data suggest that IL-29 has potential to prevent RSV disease. However, we also demonstrated that RSV efficiently circumvents this antiviral immune response and identified mechanisms by which this may occur. Our study provides new insights into RSV interaction with pediatric airway epithelium.
Airway epithelium is an extremely important barrier to respiratory pathogens. It is also the primary infection target for many respiratory viruses. Elucidating the interactions between respiratory viruses and airway epithelium is fundamental to understanding aspects of their pathogenesis. We recently developed and characterized models of respiratory syncytial virus (RSV) infection based on well-differentiated pediatric primary airway epithelial cells derived from pediatric bronchial (WD-PBECs) or nasal (WD-PNECs) brushings (1, 2). RSV is the primary viral cause of infant hospitalizations in the first year of life and is capable of repeated infections throughout life (3). Despite its original isolation in 1957 (4), no effective RSV therapies or vaccines are available. The mechanisms by which RSV causes disease and is capable of repeated infections in humans remain an enigma. Our models reproduce several hallmarks of RSV infection in vivo, suggesting that they provide authentic surrogates with which to study RSVinduced innate immune responses and interaction with human airway epithelium (1, 2).We previously reported secretion of high levels of CXCL10, an